IDSA urges Congress to support Hatch Infection Bill

Link: IDSA urges Congress to support Hatch amendments.

The Infectious Diseases Society of American is calling on members of Congress to support the Antibiotic Safety and Innovation amendment introduced by Sen. Orrin Hatch (R-UT) to the Food Drug Administration (FDA) Revitalization Act. Without innovative public policy, the practice of medicine may return to the pre-antibiotic era when acquiring a bacterial infection was often a death sentence. The FDA Revitalization Act offers an important opportunity to avert the public health crisis that antimicrobial resistance is creating in hospitals and communities across the nation and at the same time to strengthen patient safety. The Hatch amendment will:     * expand incentives to spur the development of new, effective antibiotics     * spur research on new indications or uses for approved antibiotics     * require FDA to establish and reassess antimicrobial breakpoints so that physicians have the information necessary to use antibiotics wisely and in a way that will not put patients� safety or public health at greater risk

Comments

[Christina Fielding Dibble]

SENATOR HATCH IS OF INFERIOR INTELLECTUAL CAPACTITY. THIS FACT ASIDE, HIS BILL IS FOCUSED SOLELY ON THE DEVELOPPMENT OF ANTIBIOTICS WHICH HAS FOR SOME TIME NOW BEEN IN THE BUDGET DURING THE RESEARCH FOR MEDICATIONS IN DEVELOPMENT FOR THE TREATMENT OF OTHER DISEASES LIKE AIDS. ANY POLICY ADDRESSING PREVENTION OF FURTHER INFECTION TO MASS PORTIONS OF THE POPULATION. HAS MR. HATCH PROPOSED WITHIN HIS LITIGATION ANY PROVISIONS FOR EDUCATIONAL MATERIALS FOR PRE-SCHOOLERS THEMSELVES AND FOR POST-PARTUM PARENTS OF UNINFECTED BABIES THAT WILL BE ISOLATED AND HOPEFULLY, WITH TIME A SEPERATE BUT PRESENT YOUNG GENBERATION OF GENETICALLY MRSA FREE, COULD BE A POSSIBILITY TO SAVE THE HUMAN RACE.

SEND HIM THIS IF YOU WANT.